News
Search results
Showing matches with:
Nanoparticles designed to trap and neutralise large amounts of SARS-CoV2
12 11 2024
Researchers from the IBB-UAB have developed a new class of nanostructures capable of trapping and neutralising large quantities of the SARS-CoV-2 virus particles, both in liquid solutions and on the surface of materials. These novel nanoparticles could be used to manufacture antiviral materials such as wastewater and air filters, and could be exploited to develop new tests for the early detection of COVID-19. Moreover, the nanoparticles could be redesigned to target other pathogens.
UAB researchers cure liver disease MASH by a one-time gene therapy
12 11 2024
UAB researchers have reversed metabolic dysfunction-associated steatohepatitis (MASH) in mouse models. MASH is a severe liver disease associated with obesity and type 2 diabetes that affects more than 40 million people. The results were obtained with a single intramuscular administration of the therapeutic viral vectors. The research has also determined that most obese, type 2 diabetic and MASH patients could benefit from the therapy. The results will be the basis for a future clinical trial by the biopharmaceutical company Kriya
WHO Laboratory Biosecurity Guidance document
26 06 2024
WHO publishes revised "Laboratory Biosecurity Guidance".
15 innovative UAB projects, recognized by the Indústries del Coneixement Program
15 04 2024
15 UAB researcher-driven projects have received funding from the Indústria del Coneixement grant from the Departament de Recerca i Universitats of the Generalitat de Catalunya to improve their value and transfer.
Two European partnerships on animal health and welfare and medical solutions to CBRN threats, with the participation of the UAB
26 03 2024
Researchers from four health science departments of the UAB are part of two recently launched partnership projects, promoted by the European Union through the Horizon Europe Programme and the European Defence Fund. On the one hand, EUPAHW, which aims to promote research in animal health and welfare and collaboration with other agents of society from the perspectives of one health and one welfare. On the other hand, RESILIENCE, which will research and develop new medical solutions against potential chemical, biological, radiological and nuclear (CBRN) threats.
WHO launches a mobile app for biological risk assessment
15 03 2024
RAST, the new WHO mobile application designed to assist in laboratory biorisk assessment.
October 15 is Global Handwashing Day
15 10 2023
Good hand washing technique is important to prevent the spread of germs. Think about everything you touch from the moment you wake up, come to work and come home.
The 4th edition of the WHO Laboratory Biosafety Manual has been published
01 01 2021
The 4th edition of the WHO Laboratory Biosafety Manual has finally been published in late 2020, together with the seven supplemental monographs that cover the various technical and organizational topics of biosafety.